Skip to content

Public FDA record

Z-0209-2027: Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter

Recall record Z-0209-2027 for Abiomed, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0209-2027
Company in FDA record
Abiomed, Inc.
FDA classification date
Oct 28, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2. Potential for the rotary push button (RPB) sticking and unreliable actuation impacting operator ability to select and confirm menu entries. This can result in loss of control of the console. 3. Potential AIC instability that could result in AIC start-up failure, inability to drive the pump, and the need for console exchange. 4. Software defect related to calculator process crash, leading to Negative Central Venous Pressure (CVP) values present in Pulmonary Artery Pressure (PAP) calculations.

Source facts

Action
Abiomed notified consignees on about 09/18/2026 via "URGENT MEDICAL DEVICE RECALL (REMOVAL)" letter. Consignees were informed of the issue and that affected units can continue to be used while awaiting service from Abiomed to ensure continuity of care. Consignees were instructed to identify if affected units are on hand, Abiomed will contact each consignee to coordinate the removal, update and return of affected devices, complete and return the provided business reply form by email to: Abiomed5510@sedgwick.com (or Fax to (866) 201-9339). If you have questions regarding returning this form, please contact (866) 482-2893. Inform all applicable personnel within your facility of the recall, and if any of the affected devices have been forwarded to another facility, to notify those facilities. If you have questions or concerns regarding this notice, please contact ra-abm-fieldaction@its.jnj.com or your local clinical field staff or call the Manager Product Issue Escalation & Field Actions at 978-646-1400.
Initiated
2026-09-18
Root cause
Under Investigation by firm
Distribution
Worldwide Distribution: US (nationwide) and OUS (foreign) to countries: Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Finland, France, Germany, Hong Kong, India, Ireland, Italy, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, Norway, Pakistan, Panama, Poland, Saudi Arabia, Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland, United Arab Emirates, and United Kingdom
Recall number
Z-0209-2027
Recall status
Open, Classified
CDRH record ID
222465
FDA classified
2026-10-28
Recall event number
99778

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗